Cara Haymaker

12.1k citations
169 papers · 9.2k · 6 hit papers · h-index 49

Impact in

  • Oncology top 0.2%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Pancreatic and Hepatic Oncology Research
  • Immunology top 1%
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology

Papers in

    • Cancer Immunotherapy and Biomarkers 94
    • CAR-T cell therapy research 20
    • Pancreatic and Hepatic Oncology Research 7
    • Immunotherapy and Immune Responses 26
    • T-cell and B-cell Immunology 21

Cara Haymaker

161 papers receiving 9.1k citations

Cara Haymaker's Hit Papers

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial 2023 · 173 citations
1730+3+7Years since publication4008001.2k

Peers

Cara Haymaker
Comparison fields: 5 of 107
  • Oncology 5.4k
  • Immunology 1.7k
  • Pulmonary and Respiratory Medicine 1.4k
  • Cancer Research 382
  • Otorhinolaryngology 126
Replace Chantale Bernatchez with:
Chantale Bernatchez United States
Hua Laura Liang China
Jitka Palich Fucikova Czechia
Daniela Bruni France
Liufu Deng China
Kelly Kersten United States
Sumit Kumar Subudhi United States
Vincent Chan United States
Theresa M. Salay United States
Weiyi Peng United States
Cara Haymaker relative to Chantale Bernatchez United States Chantale Bernatchez's profile →
Citations per field
00.5×1.5×
Chantale Bernatchez · 1×
Citations per year

Countries citing papers authored by Cara Haymaker

Since Specialization
Citations

This map shows the geographic impact of Cara Haymaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cara Haymaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cara Haymaker more than expected).

Fields of papers citing papers by Cara Haymaker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cara Haymaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cara Haymaker. The network helps show where Cara Haymaker may publish in the future.

Co-authors

The 25 scholars most cited alongside Cara Haymaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cara Haymaker Line = papers co-authored together Cara Haymaker links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 169 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy
Hit paper breakdown →
20151299
2
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial
Hit paper breakdown →
2021494
3 2018404
4
Identification of bacteria-derived HLA-bound peptides in melanoma
Hit paper breakdown →
2021354
5
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity
Hit paper breakdown →
2022279
6 2017217
7 2020211
8 2019203
9 2012184
10
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
Hit paper breakdown →
2023173
11 2017165
12 2020149
13
Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer
Hit paper breakdown →
2023136
14 2016132
15 2017127
16 2018126
17 2018124
18 2022121
19 2008119
20 2019116

About Cara Haymaker

Cara Haymaker is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Molecular Biology and Surgery, having authored 169 papers that have together received 9.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (94 papers), Immunotherapy and Immune Responses (26 papers), T-cell and B-cell Immunology (21 papers), CAR-T cell therapy research (20 papers), Pancreatic and Hepatic Oncology Research (7 papers), Single-cell and spatial transcriptomics (7 papers), Breast Implant and Reconstruction (5 papers) and Lung Cancer Diagnosis and Treatment (5 papers). The work is most often cited by research in Oncology (5.4k citations), Immunology (1.7k citations), Pulmonary and Respiratory Medicine (1.4k citations), Cancer Research (382 citations) and Otorhinolaryngology (126 citations). Cara Haymaker has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Chantale Bernatchez, Patrick Hwu, Marie‐Andrée Forget, Laszlo George Radvanyi, Richard Cheng Han Wu, Ignacio Ivan Wistuba, Edwin Roger Parra, Mei Jiang, Jessica Ann Chacon and Adi K. Diab. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Clinical Cancer Research, Nature Communications, Annals of Oncology and Cancer Discovery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact